APA (7th ed.) Citation

Milara, J., Contreras, S., de Diego, A., Calbet, M., Aparici, M., Morcillo, E., . . . Cortijo, J. (2019). In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients. PLoS ONE, 14(01), 1. https://doi.org/10.1371/journal.pone.0210188

Chicago Style (17th ed.) Citation

Milara, Javier, Sonia Contreras, Alfredo de Diego, Marta Calbet, Mònica Aparici, Esteban Morcillo, Montserrat Miralpeix, and Julio Cortijo. "In Vitro Anti-inflammatory Effects of AZD8999, a Novel Bifunctional Muscarinic Acetylcholine Receptor Antagonist /β2-adrenoceptor Agonist (MABA) Compound in Neutrophils from COPD Patients." PLoS ONE 14, no. 01 (2019): 1. https://doi.org/10.1371/journal.pone.0210188.

MLA (9th ed.) Citation

Milara, Javier, et al. "In Vitro Anti-inflammatory Effects of AZD8999, a Novel Bifunctional Muscarinic Acetylcholine Receptor Antagonist /β2-adrenoceptor Agonist (MABA) Compound in Neutrophils from COPD Patients." PLoS ONE, vol. 14, no. 01, 2019, p. 1, https://doi.org/10.1371/journal.pone.0210188.